The Skin microbiota: a target for Next Generation active ingredients

The skin surface is composed of molecules derived from our skin cells, our environment and from the microorganisms living on our skin. The composition and the diversity of skin microorganisms are directly linked to parameters such as temperature, pH, humidity, lipid content and oxygen gradient. The characterization based on Omics tools (metagenomic, transcriptomic, proteomic…) has highlighted the microbiota as a unique ecosystem for each individual whose role in metabolic, immune and neurological functions is now well established.

Role of commensal species

One of the next challenges will be to understand more precisely the role of commensal species composing the skin microbiota. Multiple researches have shown that Propionibacterium acnes, newly called Cutibacterium acnes, comprised different phylotypes, some of them linked to acne pathogenicity. Recently, Nakatsuji et al. (2017) reports evidence that the community of bacteria residing on normal human skin provides protection against S. aureus. Subsequently, isolated S. hominis A9 strain from normal skin was used to produce a Sh-lantibiotics with selective and efficient activity against S. aureus.

Diversity and balance matter

The diversity of skin microbiota is associated to healthy skin when its value is high. In the case of psoriasis, a high-resolution shotgun metagenomics method was used to characterise the microbiome of psoriatic patients. Results showed decrease diversity and increase in Staphylococcus with potential strain-level variations as key determinants of the psoriatic microbiome [3]. An interesting comparative study between the microbiota of Yanomami indians and US citizens led to the conclusion that the Yanomami indians exhibited highest bacterial diversity and westernisation severely seems to affect human skin micro biome diversity.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    SkinBiotherapeutics Plc

    More articles like this

    SkinBiotherapeutics Plc

    Probiotics & Skin: the next big thing in beauty?

    If we look back just a couple of decades, many people had not even heard the term ‘probiotic’, but awareness of ‘friendly bacteria’ has been gradually increasing, mainly due to the increased amount of scientific research

    SkinBiotherapeutics Plc

    Skinbiotherapeutics PLC Notice of interim results

    Skinbiotherapeutics PLC (LON:SBTX), a life sciences company focused on skin health, will publish its interim results for the six months to 31 December 2017 on 21 February 2018.   SkinBioTherapeutics is a life science company focused on

    SkinBiotherapeutics Plc

    Skinbiotherapeutics Appointment of Joint Broker

    Skinbiotherapeutics PLC (LON:SBTX), a life science company focused on skin health, announced today the appointment of Northland Capital Partners to act as the Company’s Joint Corporate Broker, alongside Turner Pope Investments, with immediate effect.   Skinbiotherapeutics is

    SkinBiotherapeutics Plc

    SkinBioTherapeutics Notification of first patent grant

    SkinBioTherapeutics plc (LON:SBTX), a life science company focused on skin health, announces the granting of the first patent for its SkinBiotix® technology in Australia. The patent granted covers the use of specific probiotic bacteria and lysates in

    SkinBiotherapeutics Plc

    SkinBioTherapeutics PLC Notice of Results

    SkinBioTherapeutics PLC (LON:SBTX) a life science company focused on skin health, will publish its full year results for the year to 30 June 2017 on Thursday, 5 October 2017.   SkinBioTherapeutics is a life science company

    SkinBiotherapeutics Plc

    Cosmetics: The next microbiome frontier

    “Love your bacteria.” That’s the tagline for Yun Probiotherapy’s line of skin cosmetics directed at those who have acne or athlete’s foot or who just want to keep their skin looking healthy. Yun’s product line, now